Prof. Dr. TANER DEMİRER

Yayın Ağı

Makaleler 193

1. Hodgkin Lenfomalı Hastalarda Tedavi Sonrası Geç Dönemde Yüksek Hematokrit Değerleri: Lenfoma ile Eritrositoz Arasında İlişki mi var?

KOYUN D., ATEŞAĞAOĞLU B., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.8, sa.3, ss.86-91, 2024 (TRDizin)

2. Anaplastic Multiple Myeloma: An Aggressive Myeloma Variant with A Poor Response to Autologous Stem Cell Transplantation

Koyun D., Doğan İ. Ö., Kuzu I., Toprak S. K., Özcan M., Demirer T.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.77, sa.4, ss.416-418, 2024 (Hakemli Dergi)

3. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Civriz Bozdag S., TOPRAK S. K., Kurt Yuksel M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Balkan medical journal , cilt.40, sa.3, ss.197-204, 2023 (SCI-Expanded, Scopus)

4. Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Kırcalı E., Cengiz Seval G., Öztürk C., Yılmaz H., Koyun D., Civriz Bozdağ S., et al.

BALKAN MEDICAL JOURNAL , cilt.40, sa.1, ss.51-56, 2023 (SCI-Expanded, Scopus)

5. Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G., Bozdağ S. C., Toprak S. K., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.8, ss.596-600, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

KOYUN D., CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.38, sa.3, ss.601-605, 2022 (SCI-Expanded, Scopus)

7. İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., ŞENOYMAK M. C., YAVUZ G., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.6, sa.2, ss.50-55, 2022 (TRDizin)

8. The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.

Toprak S. K., Korcalo E., Seval G. C., Bozdag S. C., Yuksel M. K., Topcuoglu P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded, Scopus)

9. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Ilhan O., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Topcuoglu P., et al.

BLOOD , cilt.138, 2021 (SCI-Expanded)

10. Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Sahin Eroglu D., Dalva K., Kalaci E., Toprak S. K., Civriz Bozdag S., Topcuoglu P., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , 2021 (SCI-Expanded, Scopus)

11. Comparative Analysis and Validation of CIBMTR Early Relapse Risk Score with ISS and R-ISS: Single Center Experience from Ankara University

Seval G. C., Bozdag S. C., Toprak S. K., Yuksel M. K., Topcuoglu P., Arslan O., et al.

Transplantation and Cellular Therapy , cilt.27, sa.3, ss.401, 2021 (Scopus)

12. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients

Kircali E., Seval G. C., Bozdag S. C., Yuksel M. K., Topcuoglu P., Arslan O., et al.

Transplantation and Cellular Therapy , cilt.27, sa.3, ss.271, 2021 (Scopus)

13. Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

CENGİZ SEVAL G., TOPÇUOĞLU P., DEMİRER T.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.6, ss.2799-2809, 2021 (SCI-Expanded, Scopus, TRDizin)

14. The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.74, 2021 (TRDizin)

15. Treatment of Thrombocytopenia after Allogeneic Stem Cell Transplantation with Eltrombopag

Kircali E., CENGİZ SEVAL G., KOYUN D., Ozturk C., Uslu A., CİVRİZ BOZDAĞ S., et al.

BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.410-411, 2020 (SCI-Expanded, Scopus)

16. The Influence of anti-thymocyte Globulin(ATG) on the Outcomes of Patients with AML W/wo Measurable Residual Disease(MRD) at the time of Unrelated Donor Transplantation

CENGİZ SEVAL G., Kircali E., BALTACI M. A., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., et al.

BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.204, 2020 (SCI-Expanded, Scopus)

17. Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?

CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.

BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.305-306, 2020 (SCI-Expanded, Scopus)

18. Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)

CENGİZ SEVAL G., Ulas E. B., TOPRAK S. K., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., et al.

BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.192-193, 2020 (SCI-Expanded, Scopus)

19. Bir Nakil Merkezinin 11 YıllıkAllojeneik Kök Hücre Nakli Deneyimi

Kırcalı E., SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

LLM Dergi , cilt.4, sa.3, ss.50-54, 2020 (TRDizin)

20. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation

Atilla P. A., AKKUŞ E., Atilla E., Gökmen İnan N., CİVRİZ BOZDAĞ S., Yuksel M. K., et al.

CLINICAL TRANSPLANTATION , cilt.34, sa.10, 2020 (SCI-Expanded, Scopus)

21. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

Atilla P. A., Akkus E., Atilla E., Gokmen N., Bozdag S. C., TOPRAK S. K., et al.

TRANSFUSION CLINIQUE ET BIOLOGIQUE , cilt.27, sa.3, ss.115-121, 2020 (SCI-Expanded, Scopus)

22. Our Approach in Allogeneic Stem CellTransplantation: 11 Years of Experience

Kırcalı E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.50-54, 2020 (TRDizin)

23. Our Treatment Approach to Hairy Cell Leukemia

ATACA ATİLLA P., ATİLLA E., KIRCALI E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (TRDizin)

24. Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience.

Demirer T., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Topcuoglu P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15_suppl, ss.19522, 2020 (SCI-Expanded)

25. Tüylü Hücreli Lösemide Tedavi Yaklaşımımız

ATACA ATİLLA P., ATİLLA E., Kırcalı E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (Hakemli Dergi)

26. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Seval G. C., Uslu A., Kircali E., Bozdag S. C., Toprak S. K., Yuksel M. K., et al.

Transplantation and Cellular Therapy , cilt.26, sa.3, ss.305-306, 2020 (SCI-Expanded)

27. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Seval G. C., Ozturk N., Bozdag S. C., Yuksel M. K., Topcuoglu P., Arslan O., et al.

Transplantation and Cellular Therapy , cilt.26, sa.3, ss.109-110, 2020 (SCI-Expanded)

28. Graft-versus-cancereffect and innovative approaches in the treatment of refractory solid tumors

Sahin U., DEMİRER T.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, ss.1697-1706, 2020 (SCI-Expanded, Scopus, TRDizin)

29. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT

Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.47, sa.1, ss.218-219, 2020 (SCI-Expanded, Scopus)

30. Impact of Hepatitis B Core Antibody Seropositivity on the Liver Function Tests After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Cengiz Seval G., Karaman Z., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., Arslan Ö., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.3, ss.55-59, 2019 (Hakemli Dergi)

31. Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.10, 2019 (SCI-Expanded, Scopus)

32. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

Ilhan O., Cengiz Seval G., Toprak S. K., Civriz Bozdag S., Yuksel M. K., Topcuoglu P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.37, sa.15_suppl, ss.19524, 2019 (SCI-Expanded)

33. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

Demirer T., Cengiz Seval G., Toprak S. K., Civriz Bozdag S., Yuksel M. K., Topcuoglu P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.37, sa.15_suppl, ss.19532, 2019 (SCI-Expanded)

34. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Atilla E., Topcuoglu P., Akkus E., Atilla P. A., Bozdag S. C., Yuksel M. K., et al.

Transplantation and Cellular Therapy , cilt.25, sa.3, ss.322, 2019 (SCI-Expanded)

35. Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

Seval G. C., Atilla E., Ulas B., Bozdag S. C., Toprak S. K., Yuksel M. K., et al.

Transplantation and Cellular Therapy , cilt.25, sa.3, ss.176-177, 2019 (SCI-Expanded)

36. Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation

Atilla E., Atilla P. A., CENGİZ SEVAL G., Bektas M., DEMİRER T.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.2, ss.122-131, 2019 (SCI-Expanded, Scopus, TRDizin)

37. Akut Lösemide Allojeneik Nakil Öncesi Serum Ferritin Düzeyinin Nakil Sonuçlarına Etkisi

ŞAHİN U., HASAN E., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

Lösemi Lenfoma Miyelom Hastaları ve Araştırma Eğitimi Birliği Dergisi , cilt.3, sa.1, ss.1-3, 2019 (Hakemli Dergi)

38. The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.9-13, 2019 (Hakemli Dergi)

39. Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma

Uckun F. M., Qazi S., DEMİRER T., Champlin R. E.

EBIOMEDICINE , cilt.39, ss.612-620, 2019 (SCI-Expanded, Scopus)

40. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Topcuoglu P., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Dalva K., et al.

BLOOD , cilt.132, sa.Supplement 1, ss.5776, 2018 (SCI-Expanded)

41. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., DALVA K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.4, ss.93-97, 2018 (Hakemli Dergi)

42. Is there a role of high dose chemotherapy and autologous stem cell transplantation in the treatment of Ewing's sarcoma and osteosarcomas?

Karadurmus N., Sahin U., Basgoz B. B., DEMİRER T.

JOURNAL OF BUON , cilt.23, sa.5, ss.1235-1241, 2018 (SCI-Expanded, Scopus)

43. Primer Mediastinal Büyük BHücreli Lenfoma HastalarımızınTedavi Sonuçlarının Geriye DönükDeğerlendirilmesi

ATİLLA E., ATACA ATİLLA P., Cengiz Seval G., TOPRAK S. K., İLHAN O., ARSLAN Ö., et al.

Türkiye’de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.3, ss.60-64, 2018 (TRDizin)

44. Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma

Sahin U., DEMİRER T.

JOURNAL OF CLINICAL APHERESIS , cilt.33, sa.3, ss.357-370, 2018 (SCI-Expanded, Scopus)

45. Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience.

CENGİZ SEVAL G., Bulat B., Ozel F., Tasci O., KUZU I., CİVRİZ BOZDAĞ S., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded)

46. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

Hematology Oncology and Stem Cell Therapy , cilt.11, sa.1, ss.13-17, 2018 (Scopus)

47. Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation

CENGİZ SEVAL G., TOPÇUOĞLU P., DEMİRER T.

BALKAN MEDICAL JOURNAL , cilt.35, sa.2, ss.131-140, 2018 (SCI-Expanded, Scopus, TRDizin)

48. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.

Atilla P. A., Atilla E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.

Hematology/oncology and stem cell therapy , cilt.11, sa.1, ss.13-17, 2018 (Scopus)

49. Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

Ilhan O., Seval G. C., Toprak S. K., Bozdag S. C., Yuksel M. K., Topcuoglu P., et al.

Transplantation and Cellular Therapy , cilt.24, sa.3, ss.142, 2018 (SCI-Expanded)

50. Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

Atilla E., Yalciner M., Ailla P. A., Ates C., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

ANTIVIRAL THERAPY , cilt.23, sa.8, ss.647-653, 2018 (SCI-Expanded, Scopus)

51. Adult Stem Cells and Medicine

CİVRİZ BOZDAĞ S., YÜKSEL M., DEMİRER T.

CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 1: STEM CELLS IN REGENERATIVE MEDICINE: ADVANCES AND CHALLENGES , cilt.1079, ss.17-36, 2018 (SCI-Expanded)

52. A review of allogeneic hematopoietic stem cell transplantation in metastatic breast cancer

Karadurmus N., Sahin U., Basgoz B. B., Arpaci F., DEMİRER T.

International Journal of Hematology-Oncology and Stem Cell Research , cilt.12, sa.2, ss.111-116, 2018 (Scopus) Sürdürülebilir Kalkınma

53. Extracorporeal photochemotherapy in mycosis fungoides

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., Topcuoglu P., et al.

TRANSFUSION CLINIQUE ET BIOLOGIQUE , cilt.24, sa.4, ss.454-457, 2017 (SCI-Expanded, Scopus)

54. A review of late complications of allogeneic hematopoietic stem cell transplantations

Atilla E., Atilla P. A., TOPRAK S. K., DEMİRER T.

CLINICAL TRANSPLANTATION , cilt.31, sa.10, 2017 (SCI-Expanded, Scopus)

55. A review of infectious complications after haploidentical hematopoietic stem cell transplantations

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., DEMİRER T.

INFECTION , cilt.45, sa.4, ss.403-411, 2017 (SCI-Expanded, Scopus)

56. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation

Gunduz M., Ozen M., Sahin U., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.

CLINICAL TRANSPLANTATION , cilt.31, sa.7, 2017 (SCI-Expanded, Scopus)

57. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?

Atilla P. A., Ozturk S. M. B., DEMİRER T.

TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.2, ss.190-198, 2017 (SCI-Expanded, Scopus)

58. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?

Atilla E., Atilla P. A., DEMİRER T.

INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.105, sa.3, ss.257-264, 2017 (SCI-Expanded, Scopus)

59. An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice

Ozaydin S., Sahin U., Karadurmus N., Arpaci F., DEMİRER T.

JOURNAL OF BUON , cilt.22, sa.2, ss.306-311, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPRAK S. K., et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.23, sa.3, 2017 (SCI-Expanded)

61. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

Ozen M., Ustun C., Ozturk B., TOPÇUOĞLU P., Arat M., Gunduz M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded, Scopus, TRDizin)

62. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation

Atilla E., TOPRAK S. K., DEMİRER T.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.1-9, 2017 (SCI-Expanded, Scopus, TRDizin)

63. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations

Atilla E., Atilla P. A., DEMİRER T.

BALKAN MEDICAL JOURNAL , cilt.34, sa.1, ss.1-9, 2017 (SCI-Expanded, Scopus, TRDizin)

64. Hairy Cell Leukemia Presenting with Isolated Bone Lesions

GÜNDÜZ M., ÖZEN M., YÜKSEL S., KUZU I., DEMİRER T.

LLM Dergi , cilt.1, sa.1, ss.14-17, 2017 (Hakemli Dergi)

65. Iron Overload in Hematopoietic Stem Cell Transplantation Reply

Atilla E., TOPRAK S. K., Demirer T.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103, 2017 (SCI-Expanded, Scopus, TRDizin)

66. Re: Iron overload in hematopoietic stem cell transplantation Re: Hematopoetik kök hücre transplantasyonunda aşırı demir yüklenmesi

Atilla E., TOPRAK S. K., DEMİRER T.

Turkish Journal of Hematology , cilt.34, sa.1, ss.103, 2017 (SCI-Expanded, Scopus, TRDizin)

67. Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Ilhan O., Atilla E., Ataca Atilla P., Civriz Bozdag S., Kurt Yuksel M., Toprak S. K., et al.

BLOOD , cilt.128, sa.22, ss.4939, 2016 (SCI-Expanded)

68. An overview of hematopoietic stem cell transplantation related thrombotic complications

Sahin U., Atilla P. A., Atilla E., TOPRAK S. K., DEMİRER T.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.107, ss.149-155, 2016 (SCI-Expanded, Scopus)

69. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation

Sahin U., TOPRAK S. K., Atilla P. A., Atilla E., DEMİRER T.

JOURNAL OF INFECTION AND CHEMOTHERAPY , cilt.22, sa.7-8, ss.505-514, 2016 (SCI-Expanded, Scopus)

70. Non-Infectious Early Complications of Allogeneic Stem Cell Transplantations

Atilla P. A., Atilla E., TOPRAK S. K., DEMİRER T.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.4, ss.239-250, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

71. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Breast Cancer: Is There Still a Hope?

DEMİRER T.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.182-187, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

72. A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction

Ozen M., Yilmaz G., Coskun B., TOPÇUOĞLU P., Ozturk B., Gunduz M., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus, TRDizin)

73. Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer

KARADURMUS N., ŞAHİN U., BASGOZ B. B., ARPACI F., DEMİRER T.

World Journal of Transplantation , cilt.6, sa.4, ss.675-681, 2016 (Hakemli Dergi)

74. Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

Gurman G., Ataca P., Atilla E., Civriz Bozdag S., Toprak S. K., Yuksel M. K., et al.

BLOOD , cilt.126, sa.23, ss.1952, 2015 (SCI-Expanded)

75. Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Atilla E., Ataca P., Toprak S. K., Yuksel M. K., Topcuoglu P., Arslan O., et al.

BLOOD , cilt.126, sa.23, ss.5483, 2015 (SCI-Expanded)

76. Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Merter M., Atilla E., Sahin U., Civriz Bozdag S., Kurt Yuksel M., Topcuoglu P., et al.

BLOOD , cilt.126, sa.23, ss.5456, 2015 (SCI-Expanded)

77. Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation

Martino M., Lanza F., DEMİRER T., Moscato T., Secondino S., Pedrazzoli P.

EXPERT OPINION ON BIOLOGICAL THERAPY , cilt.15, sa.2, ss.195-211, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center

Ozen M., CİVRİZ BOZDAĞ S., Cakmak G., TOPÇUOĞLU P., Eroglu A. H., Glunduz M., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded, Scopus, TRDizin)

79. Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

Topcuoglu P., Ataca P., Bozdag S. C., Toprak S. K., Arslan O., Ozcan M., et al.

BLOOD , cilt.124, sa.21, ss.5887, 2014 (SCI-Expanded)

80. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience of a Single Center

Sahin U., Merter M., Ataca P., Atilla E., Atesagaoglu B., Pekcan G., et al.

BLOOD , cilt.124, sa.21, ss.5150, 2014 (SCI-Expanded)

81. Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation

Topcuoglu P., Gunduz M., Ozen M., Civriz Bozdag S., Kocak Toprak S., Arslan O., et al.

BLOOD , cilt.124, sa.21, ss.5891, 2014 (SCI-Expanded)

82. Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt’s Lymphoma: A Single Center Experience

Atilla E., Sahin U., Ataca P., Uslu A., Kircali E., Atesagaoglu B., et al.

BLOOD , cilt.124, sa.21, ss.5448, 2014 (SCI-Expanded)

83. Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

Ilhan O., Ataca P., Atilla E., Toprak S. K., Kaygusuz G., Kuzu I., et al.

BLOOD , cilt.124, sa.21, ss.5555, 2014 (SCI-Expanded)

84. Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ?

Gunduz M., Ataca P., Ozen M., Atilla E., Bozdag S. C., Toprak S. K., et al.

BLOOD , cilt.124, sa.21, ss.5328, 2014 (SCI-Expanded)

85. Response to: 'Are there still reasons to believe that high-dose chemotherapy plays a role in breast cancer management?'

DEMİRER T.

Bone Marrow Transplantation , cilt.48, sa.2, ss.306, 2013 (SCI-Expanded)

86. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.

World Journal of Endocrine Surgery , cilt.4, sa.3, ss.118-119, 2012 (Scopus)

87. Novel agents and approaches for stem cell mobilization in normal donors and patients

Bakanay Ş., DEMİRER T.

Bone Marrow Transplantation , cilt.47, sa.9, ss.1154-1163, 2012 (SCI-Expanded)

88. Intense ga-68 dotatate uptake in recurrent mtc patients

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.

WORLD JOURNAL OF ENDOCRINE SURGERY , cilt.4, sa.3, ss.118-119, 2012 (Scopus)

89. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: Overview of six randomized trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Caputo J., Smith D. A., et al.

Journal of Clinical Oncology , cilt.29, sa.24, ss.3224-3231, 2011 (SCI-Expanded)

90. High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Caputo J., Rodenhuis S., et al.

Journal of Clinical Oncology , cilt.29, sa.24, ss.3214-3223, 2011 (SCI-Expanded)

91. Allogeneic hematopoietic stem cell transplantation in ovarian cancer - The EBMT experience

Bay J., Cabrespine-Faugeras A., Tabrizi R., Blaise D., Viens P., Ehninger G., et al.

International Journal of Cancer , cilt.127, sa.6, ss.1446-1452, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

92. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF

Ozcelik T., Topcuoglu P., BEKSAÇ M., Ozcan M., Arat M., Biyikli Z., et al.

BONE MARROW TRANSPLANTATION , cilt.44, sa.12, ss.779-783, 2009 (SCI-Expanded, Scopus)

93. Severe Henoch-Schonlein Purpura Induced by Cytarabine

Aktas B., TOPÇUOĞLU P., Kurt O. K., ENSARİ A., Demirer T.

ANNALS OF PHARMACOTHERAPY , cilt.43, sa.4, ss.792-793, 2009 (SCI-Expanded, Scopus)

94. Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience

Aglietta M., Barkholt L., Schianca F. C., Caravelli D., Omazic B., Minotto C., et al.

Biology of Blood and Marrow Transplantation , cilt.15, sa.3, ss.326-335, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

95. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience

İLHAN O., TOPÇUOĞLU P., Arat M., Soydan E. A., YÜKSEL M., ARSLAN Ö., et al.

Turkish Journal of Hematology , cilt.25, sa.2, ss.87-93, 2008 (SCI-Expanded)

96. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

Ladenstein R., Poetschger U., Hartman O., Pearson A. D. J., Klingebiel T., Castel V., et al.

BONE MARROW TRANSPLANTATION , cilt.41, 2008 (SCI-Expanded, Scopus)

97. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors

DEMİRER T., Barkholt L., Blaise D., Pedrazzoli P., Aglietta M., Carella A. M., et al.

NATURE CLINICAL PRACTICE ONCOLOGY , cilt.5, sa.5, ss.256-267, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Ueno N. T., Rizzo J. D., Demirer T., Cheng Y. C., Hegenbart U., Zhang M., et al.

BONE MARROW TRANSPLANTATION , cilt.41, sa.6, ss.537-545, 2008 (SCI-Expanded, Scopus)

99. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: The experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party

De Giorgi U., Blaise D., Lange A., Viens P., Marangolo M., Madroszyk A., et al.

BONE MARROW TRANSPLANTATION , cilt.40, sa.11, ss.1045-1048, 2007 (SCI-Expanded)

100. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults

Pedrazzoli P., Rosti G., Secondino S., Carminati O., Demirer T.

SEMINARS IN HEMATOLOGY , cilt.44, sa.4, ss.286-295, 2007 (SCI-Expanded, Scopus)

101. Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation

Secondino S., Carrabba M. G., Pedrazzoli P., Castagna L., Spina F., Grosso F., et al.

HAEMATOLOGICA , cilt.92, sa.3, ss.418-420, 2007 (SCI-Expanded, Scopus)

102. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults

Pedrazzoli P., Ledermann J. A., Lotz J. -., Leyvraz S., Aglietta M., Rosti G., et al.

ANNALS OF ONCOLOGY , cilt.17, sa.10, ss.1479-1488, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

103. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., et al.

ANNALS OF ONCOLOGY , cilt.17, sa.7, ss.1134-1140, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

104. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Ljungman P., Urbano-Ispizua A., Cavazzana-Calvo M., Demirer T., Dini G., Einsele H., et al.

BONE MARROW TRANSPLANTATION , cilt.37, sa.5, ss.439-449, 2006 (SCI-Expanded, Scopus)

105. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation

Peccatori J., Barkholt L., Demirer T., Sormani M., Bruzzi P., Ciceri F., et al.

CANCER , cilt.104, sa.10, ss.2099-2103, 2005 (SCI-Expanded, Scopus)

106. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours

De Giorgi U., Rosti G., Slavin S., Yaniv I., Harousseau J., Ladenstein R., et al.

BRITISH JOURNAL OF CANCER , cilt.93, sa.4, ss.412-417, 2005 (SCI-Expanded, Scopus)

107. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Bengala C., Guarneri V., Ledermann J., Rosti G., Wandt H., Lotz J., et al.

BONE MARROW TRANSPLANTATION , cilt.36, sa.1, ss.25-31, 2005 (SCI-Expanded, Scopus)

108. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

De Giorgi U., Demirer T., Wandt H., Taverna C., Siegert W., Bornhauser M., et al.

ANNALS OF ONCOLOGY , cilt.16, sa.1, ss.146-151, 2005 (SCI-Expanded, Scopus)

109. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party

Rosti G., De Giorgi U., Wandt H., Lioure B., Leyvraz S., Kolbe K., et al.

BONE MARROW TRANSPLANTATION , cilt.34, sa.12, ss.1033-1037, 2004 (SCI-Expanded, Scopus)

110. Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Arat M., Arslan O., Soydan E. A., Ayyildiz E., Dalva K., Tol M., et al.

BLOOD , cilt.104, sa.11, ss.5009, 2004 (SCI-Expanded)

111. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation

Demirer T., Ayli M., Fen T., Ozcan M., Arat M., Buyukberber S., et al.

Bone Marrow Transplantation , cilt.34, sa.9, ss.781-786, 2004 (SCI-Expanded, Scopus)

112. The Comparison of Myeloablative Versus Reduced Intensity Conditioning Regimen in ABO Mismatched Allogeneic Hematopoietic Cell Transplantation.

Topcuoglu P., Arat M., Bolukbasi T., Soydan E., Ozer Y., Ozcan M., et al.

BLOOD , cilt.104, sa.11, ss.5146, 2004 (SCI-Expanded)

113. Hematopoetic stem cell transplantation for solid tumors in Europe

Gratwohl A., Baldomero H., Demirer T., Rosti G., Dini G., Ladenstein R., et al.

ANNALS OF ONCOLOGY , cilt.15, sa.4, ss.653-660, 2004 (SCI-Expanded, Scopus)

114. Second-line high-dose chemotherapy in patients with extragonadial nonseminomatous germ cell tumors: the experience of the European Group for Blood and Marrow Transplantation (EBMT)

De Giorgi U., DEMİRER T., Wandt H., Taverna C., Siegert W., Borhauser M., et al.

ANNALS OF ONCOLOGY , cilt.15, ss.121, 2004 (SCI-Expanded)

115. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients

Kroger N., Damon L., Zander A., Wandt H., Derigs G., Ferrante P., et al.

BONE MARROW TRANSPLANTATION , cilt.32, sa.12, ss.1153-1157, 2003 (SCI-Expanded, Scopus)

116. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999

Pedrazzoli P., Ferrante P., Kulekci A., Schiavo R., De Giorgi U., Carminati O., et al.

BONE MARROW TRANSPLANTATION , cilt.32, sa.5, ss.489-494, 2003 (SCI-Expanded, Scopus)

117. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation

Demirer T., Uysal V., Ayli M., Genc Y., Ilhan O., Koc H., et al.

BONE MARROW TRANSPLANTATION , cilt.31, sa.9, ss.755-761, 2003 (SCI-Expanded, Scopus)

118. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation

Kroger N., Zander A., Martinelli G., Ferrante P., Moraleda J., Da Prada G., et al.

ANNALS OF ONCOLOGY , cilt.14, sa.4, ss.554-558, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. CD34+cells in hematopoietic stem cell transplantation

Demirer T.

TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES , cilt.534, ss.107-118, 2003 (SCI-Expanded)

120. CD34+ cells in hematopoietic stem cell transplantation

DEMİRER T.

Advances in Experimental Medicine and Biology , cilt.534, ss.107-118, 2003 (Scopus)

121. The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation

ARSLAN Ö., Coşkun H. Ş., Arat M., Soydan E., ÖZCAN M., GÜRMAN G., et al.

Turkish Journal of Haematology , cilt.19, sa.3, ss.401-409, 2002 (SCI-Expanded)

122. The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation

Demirer T., Ayli M., Dagli M., Fen T., Haznedar R., Ustael N., et al.

BONE MARROW TRANSPLANTATION , cilt.30, sa.10, ss.703-704, 2002 (SCI-Expanded)

123. Monitoring of peripheral blood CD34+cell counts on the first day of apheresis is highly predictive for efficient CD34+cell yield

Demirer T., Ilhan O., Ayli M., Arat M., Dagli M., Ozcan M., et al.

THERAPEUTIC APHERESIS , cilt.6, sa.5, ss.384-389, 2002 (SCI-Expanded)

124. The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplant.

Arslan Ö., Coşkun H. Ş., Arat M., Soydan E., Özcan M., Gürman G., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.19, sa.3, ss.401-9, 2002 (Scopus)

125. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation.

Demirer T., Ayli M., Dagli M., Haznedar R., Genc Y., Fen T., et al.

British journal of haematology , cilt.118, sa.4, ss.1104-11, 2002 (SCI-Expanded, Scopus)

126. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

Demirer T., Dagli M., Ilhan O., Ayli M., Haznedar R., Fen T., et al.

BONE MARROW TRANSPLANTATION , cilt.29, sa.11, ss.893-897, 2002 (SCI-Expanded, Scopus)

127. Does donor recipient ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation?

Arslan O., Arat M., Soydan E., COŞKUN H. Ş., Topcuoglu P., Ozcan M., et al.

BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded)

128. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF

Demirer T., Ayli M., Ozcan M., Gunel N., Haznedar R., Dagli M., et al.

BRITISH JOURNAL OF HAEMATOLOGY , cilt.116, sa.2, ss.468-474, 2002 (SCI-Expanded, Scopus)

129. An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration.

Arat M., Ulusoy V., Demirer T., Uysal A., Ozcan M., Dincer S., et al.

Leukemia & lymphoma , cilt.43, sa.1, ss.145-8, 2002 (SCI-Expanded)

130. Plasmacytoma in the bilateral breast

Daǧli M., DEMİRER T., Ayli M., Haznedar R., GÜNEL N., Sucak G., et al.

Turkish Journal of Haematology , cilt.19, sa.4, ss.481-483, 2002 (SCI-Expanded)

131. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte-colony stimulating factor (rh-GSCF): A randomized evaluation of different doses of rh-G-CSF.

Demirer T., Ayli M., Arat M., Ozcan M., Gunel N., Haznedar R., et al.

BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded)

132. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 L versus 10L.

Demirer T., Ayli M., Arat M., Gunel N., Ozcan M., Haznedar R., et al.

BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded)

133. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

DEMİRER T., Ilhan O., Arat M., YAVUZ Y., ÖZCAN M. E., DALVA K., et al.

Journal of Clinical Apheresis , cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded)

134. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

Ozcan M., Ustun C., Akcaglayan E., Akan H., Arslan O., Ilhan O., et al.

BONE MARROW TRANSPLANTATION , cilt.27, sa.5, ss.499-505, 2001 (SCI-Expanded, Scopus)

135. High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors

Demirer T., Ilhan O., Ayli M., Arat M., Fen T., Ozcan M., et al.

BONE MARROW TRANSPLANTATION , cilt.27, 2001 (SCI-Expanded)

136. CD41+and CD42+hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

Demirer T., Ilhan O., Arat M., Genc Y., Ozcan M., Dalva K., et al.

JOURNAL OF CLINICAL APHERESIS , cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded, Scopus)

137. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY), epirubicin and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with breast and ovarian cancer.

Demirer T., Ayli M., Demirer A., Ulusoy V., Fen T., Celik Z., et al.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

138. Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.

Demirer T., Ilhan O., Ayli M., Arat M., Fen T., Haznedar R., et al.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded)

139. The value of peripheral blood CD34(+) cell quantification in autologous hematopoietic stem cell apheresis.

Ilhan O., Arslan O., Arat M., Ozcan M., GÜRMAN G., Dalva K., et al.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded)

140. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY), etoposide and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with hematologic malignancies and solid tumors.

Demirer T., Ayli M., Demirer A., Fen T., Haznedar R., Celik Z., et al.

BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded)

141. Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation

Demirer S., Aydintug S., Ustun C., Turkmen E., Tuzun A., Simsek S., et al.

CLINICAL NUTRITION , cilt.19, sa.4, ss.253-258, 2000 (SCI-Expanded, Scopus)

142. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital

Arslan O., COŞKUN H. Ş., Arat M., Celebi H., Ozcan M., GÜRMAN G., et al.

BONE MARROW TRANSPLANTATION , cilt.25, sa.12, ss.1229-1232, 2000 (SCI-Expanded, Scopus)

143. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

Demirer T., Ilhan O., Mandel N., Arat M., Gunel N., Celebi H., et al.

BONE MARROW TRANSPLANTATION , cilt.25, sa.7, ss.697-703, 2000 (SCI-Expanded, Scopus)

144. Primary low-grade lymphomas of the intestine - Case 1: Immunoproliferative small intestinal disease

Demirer T., Celebi H., Akcaglayan E., Ustun C., Demirer S., Ekinci C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.17, sa.11, ss.3682-3684, 1999 (SCI-Expanded)

145. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report

Üstün C., Çelebi H., Arat M., ÖZCAN M., Dilek I., GÜRMAN G., et al.

Therapeutic Apheresis , cilt.3, sa.3, ss.275-277, 1999 (SCI-Expanded)

146. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation

Demirer T., Celebi H., Arat M., Ustun C., Demirer S., Dilek I., et al.

BONE MARROW TRANSPLANTATION , cilt.24, sa.3, ss.335-337, 1999 (SCI-Expanded, Scopus)

147. Peripheral blood stem cell mobilization for high-dose chemotherapy

Demirer T., Bensinger W., Buckner C.

JOURNAL OF HEMATOTHERAPY , cilt.8, sa.2, ss.103-113, 1999 (SCI-Expanded, Scopus)

148. Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

GÜRMAN G., Ustun C., Arslan O., BEKSAÇ M., Konuk N., Arat M., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded)

149. The effect of G-CSF in the first 100 days of allogeneic peripheral blood stem cell transplantation.

Ozcan M., Ustun C., Ilhan O., Beksac M., Akcaglayan E., GÜRMAN G., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded)

150. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY) - Paclitaxel and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with breast cancer: Ibni Sina experience

Arat M., Demirer T., Ilhan O., Koc H., Ustun C., Celebi H., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

151. A protocol proposal comparing conventional approach with high-dose chemotherapy (HDC) and peripheral blood stem cell transplantation (PBSCT) in patients with small cell lung cancer limited to thorax.

Demirer T., Arat M., Koc H., Ilhan O., Celebi H., Ozcan M., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

152. The influence of CD41+ and CD42+ peripheral blood stem cells on platelet engraftment after allo PBSCT.

Ilhan O., Demirer T., Arat M., Dalva K., COŞKUN H. Ş., BEKSAÇ M., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded)

153. Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation.

Ustun C., Ozcan M., Beksac M., Ilhan O., Cakir M., GÜRMAN G., et al.

BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded)

154. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse

Üstün C., ARSLAN Ö., BEKSAÇ M., Koç H., GÜRMAN G., Özçelik T., et al.

Biology of Blood and Marrow Transplantation , cilt.5, sa.1, ss.28-35, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

155. Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease

Üstün C., ÖZCAN M., GÜRMAN G., Çakir M., Erekul S., AKYOL G., et al.

Pathology and Oncology Research , cilt.5, sa.3, ss.229-232, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

156. The effect of G-CSF in the first 100 days of allogeneic peripheral blood stem cell transplantation.

Ozcan M., Ustun C., Ilhan O., BEKSAÇ M., Akcaglayan E., GÜRMAN G., et al.

BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded)

157. Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

GÜRMAN G., Ustun C., Arslan O., BEKSAÇ M., Konuk N., Arat M., et al.

BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded)

158. Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation.

Ustun C., Ozcan M., BEKSAÇ M., Ilhan O., Cakir M., GÜRMAN G., et al.

BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)

159. Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers.

Ustun C., Idilman R., Ozcan M., Akan H., Karayalcin S., GÜRMAN G., et al.

HEPATOLOGY , cilt.28, sa.4, 1998 (SCI-Expanded) Sürdürülebilir Kalkınma

160. Acute myeloblastic leukemia associated with hyperleukocytosis and diabetes insipidus

Dilek I., Uysal A., Demirer T., Koc H., Ozcan M., Keles H., et al.

LEUKEMIA & LYMPHOMA , cilt.30, sa.5-6, ss.657-660, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

161. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia

Dilek I., Demirer T., Ustun C., Arat M., Koc H., BEKSAÇ M., et al.

BONE MARROW TRANSPLANTATION , cilt.21, sa.11, ss.1159-1161, 1998 (SCI-Expanded, Scopus)

162. Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization

Williams O., DEMİRER T., Lilleby K., Buckner C. D., Bensinger W.

Journal of Clinical Apheresis , cilt.13, sa.1, ss.1-6, 1998 (SCI-Expanded, Scopus)

163. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer

Holmberg L., Demirer T., Rowley S., Buckner C., Goodman G., Maziarz R., et al.

BONE MARROW TRANSPLANTATION , cilt.22, sa.7, ss.651-659, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

164. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor

Demirer T., Buckner C., Storer B., Lilleby K., Rowley S., Clift R., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.15, sa.2, ss.684-690, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

165. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy

Bensinger W., Buckner C., Shannon-Dorcy K., Rowley S., Appelbaum F., Benyunes M., et al.

Blood , cilt.88, sa.11, ss.4132-4138, 1996 (Scopus)

166. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation

Bensinger W., Clift R., Martin P., Appelbaum F., Demirer T., Gooley T., et al.

BLOOD , cilt.88, sa.7, ss.2794-2800, 1996 (SCI-Expanded, Scopus)

167. Syngeneic marrow transplantation in patients with multiple myeloma

Bensinger W., DEMİRER T., Buckner C., Appelbaum F., Storb R., Lilleby K., et al.

Bone Marrow Transplantation , cilt.18, sa.3, ss.527-531, 1996 (SCI-Expanded, Scopus)

168. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: Comparison of autologous bone marrow and peripheral blood stem cells

Brunvand M., Bensinger W., Soll E., Weaver C., Rowley S., Appelbaum F., et al.

Bone Marrow Transplantation , cilt.18, sa.1, ss.131-141, 1996 (SCI-Expanded, Scopus)

169. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia

DEMİRER T., Petersen F., Bensinger W., Appelbaum F., Fefer A., Rowley S., et al.

Bone Marrow Transplantation , cilt.18, sa.1, ss.29-34, 1996 (SCI-Expanded, Scopus)

170. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease

Schiffman K., Bensinger W., Appelbaum F., Rowley S., Lilleby K., Clift R., et al.

Bone Marrow Transplantation , cilt.17, sa.6, ss.943-950, 1996 (SCI-Expanded, Scopus)

171. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

DEMİRER T., Buckner C., Gooley T., Appelbaum F., Rowley S., Chauncey T., et al.

Bone Marrow Transplantation , cilt.17, sa.6, ss.937-941, 1996 (SCI-Expanded, Scopus)

172. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer

DEMİRER T., Buckner C., Appelbaum F., Clift R., Storb R., Myerson D., et al.

Bone Marrow Transplantation , cilt.17, sa.5, ss.769-774, 1996 (SCI-Expanded, Scopus)

173. Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels

DEMİRER T., Buckner C., Appelbaum F., Bensinger W., Sanders J., Lambert K., et al.

Bone Marrow Transplantation , cilt.17, sa.4, ss.491-495, 1996 (SCI-Expanded, Scopus)

174. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy

Bensinger W., Buckner C., Rowley S., DEMİRER T., Storb R., Appelbaum F., et al.

Bone Marrow Transplantation , cilt.17, sa.SUPPL. 2, 1996 (Scopus)

175. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels

DEMİRER T., Buckner C., Appelbaum F., Lambert K., Bensinger W., Clift R., et al.

Bone Marrow Transplantation , cilt.17, sa.3, ss.341-346, 1996 (SCI-Expanded, Scopus)

176. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma

Bensinger W., Rowley S., Demirer T., Lilleby K., Schiffman K., Clift R., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.5, ss.1447-1456, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

177. Transplantation of allogeneic peripheral blood stem cells.

Bensinger W., Buckner C., DEMİRER T., Storb R., Appelbaum F.

Bone marrow transplantation , cilt.17 Suppl 2, 1996 (Scopus)

178. Optimization of peripheral flood stem cell mobilization

Demirer T., Buckner C., Bensinger W.

STEM CELLS , cilt.14, sa.1, ss.106-116, 1996 (SCI-Expanded, Scopus)

179. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor

Bensinger W., Clift R., Anasetti C., Appelbaum F., Demirer T., Rowley S., et al.

STEM CELLS , cilt.14, sa.1, ss.90-105, 1996 (SCI-Expanded, Scopus)

180. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia

DEMİRER T., Buckner C., Appelbaum F., Petersen F., Rowley S., Weaver C., et al.

Bone Marrow Transplantation , cilt.15, sa.6, ss.915-922, 1995 (Scopus)

181. ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE AND ESCALATING DOSES OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN PATIENTS WITH ADVANCED LYMPHOID MALIGNANCIES - A PHASE I/II TRIAL

DEMIRER T., PETERSEN F., APPELBAUM F., BARNETT T., SANDERS J., DEEG H., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.32, sa.4, ss.1103-1109, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

182. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation

DEMİRER T., Gooley T., Buckner C., Petersen F., Lilleby K., Rowley S., et al.

Bone Marrow Transplantation , cilt.15, sa.6, ss.907-913, 1995 (SCI-Expanded, Scopus)

183. Fatal bone marrow necrosis following fludarabine administration in a patient with indolent lymphoma

Aboulafia D. M., DEMİRER T.

Leukemia and Lymphoma , cilt.19, sa.1-2, ss.181-184, 1995 (SCI-Expanded, Scopus)

184. Optimization of peripheral blood stem cell collection.

DEMİRER T., Bensinger W.

Current opinion in hematology , cilt.2, sa.3, ss.219-226, 1995 (Scopus)

185. FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS

BENSINGER W., APPELBAUM F., ROWLEY S., STORB R., SANDERS J., LILLEBY K., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.10, ss.2547-2555, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

186. FLOW CYTOMETRIC MEASUREMENT OF PROLIFERATION-ASSOCIATED NUCLEAR ANTIGEN P105 AND DNA CONTENT IN IMMUNO-PROLIFERATIVE SMALL-INTESTINAL DISEASE (IPSID)

DEMIRER T., UZUNALIMOGLU O., ANDERSON T., KOETHE S., MCFADDEN P., DEMIRER S., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.58, sa.1, ss.25-30, 1995 (SCI-Expanded)

187. HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY

DEMIRER T., WEAVER C., BUCKNER C., PETERSEN F., BENSINGER W., SANDERS J., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.3, ss.596-602, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

188. PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER PACLITAXEL, CYCLOPHOSPHAMIDE, AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH BREAST AND OVARIAN-CANCER

DEMIRER T., ROWLEY S., BUCKNER C., APPELBAUM F., LILLEBY K., STORB R., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.7, ss.1714-1719, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

189. Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma

DEMİRER T., Ravits J., Aboulafia D.

Southern Medical Journal , cilt.87, sa.11, ss.1186-1189, 1994 (SCI-Expanded, Scopus)

190. Four varied cases of intravascular lymphomatosis and a literature review

DEMİRER T., Dail D. H., Aboulafia D. M.

Cancer , cilt.73, sa.6, ss.1738-1745, 1994 (Scopus)

191. Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease

DEMİRER T., Buckner C. D., Lilleby K., Weaver C., Longin K., Appelbaum F. R., et al.

Cancer , cilt.74, sa.2, ss.715-721, 1994 (Scopus)

192. INTRATUMOR HETEROGENEITY OF DNA-PLOIDY AND CORRELATIONS WITH CLINICAL STAGE AND HISTOLOGIC GRADE IN PROSTATE-CANCER

KUCUK O., DEMIRER T., GILMANSACHS A., TAW I., MANGOLD M., SINGH S., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.54, sa.3, ss.171-174, 1993 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

193. DIET AND STOMACH-CANCER INCIDENCE - A CASE CONTROL STUDY IN TURKEY

DEMIRER T., ICLI F., UZUNALIMOGLU O., KUCUK O.

CANCER , cilt.65, sa.10, ss.2344-2348, 1990 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 178

1. GÜNCEL KLAVUZLAR EŞLİĞİNDE KLİNİKTE MASTOSİTOZ: TEK MERKEZ DENEYİMİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

2. MİKOSİZ FUNGOİDES VE SEZARY SENDROMLU HASTALARDA BRENTUXİMAB VEDOTİN TEDAVİSİNİN UZUN DÖNEM SONUÇLARI

SÖNMEZ G. M., ÖZSAN İ., DÜZ B., ŞANLI H., CENGİZ SEVAL G., DALVA K., et al.

50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

3. Prognostic evaluation of PET/CT in residual post-chemotherapy +/- RT masses in patients with Hodgkin Lymphoma and its impact on survival

BEKTAŞ M., KAR İ., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.

11TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, 19 - 22 Eylül 2024, (Tam Metin Bildiri)

4. Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Koyun D., Şahin U., Cengiz Seval G., Gören D., Gökmen A., Civriz Bozdağ S., et al.

65th ASH® Annual Meeting and Exposition, California, Amerika Birleşik Devletleri, 9 - 12 Aralık 2023, ss.3617-3619, (Tam Metin Bildiri)

5. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Karakaya B., Yilmaz H., Ermis G. Y., Cengiz Seval G., Bozdag S. C., Toprak S. K., et al.

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.457-458, (Özet Bildiri)

6. ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.

49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.301-302, (Özet Bildiri)

7. EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

Beksaç M., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians, Paris, Fransa, 23 Nisan 2023, cilt.58, ss.107, (Tam Metin Bildiri)

8. P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

BEKSAÇ M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, Fransa, 23 Nisan 2023, (Tam Metin Bildiri)

9. The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, Amerika Birleşik Devletleri, 10 - 13 Aralık 2022, cilt.140, ss.12673-12674, (Özet Bildiri)

10. The efficacy and safety of second allogeneic hematopoietic stem cell transplantation

TOPRAK S. K., KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

2022 ASCO Annual Meeting, Amerika Birleşik Devletleri, 01 Haziran 2022, (Tam Metin Bildiri)

11. Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Amerika Birleşik Devletleri, 19 - 22 Mart 2022, (Tam Metin Bildiri)

12. Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience

İLHAN O., YAVUZ G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Amerika Birleşik Devletleri, 19 - 22 Mart 2022, (Tam Metin Bildiri)

13. İKİNCİ ALLOJENEİK KÖK HÜCRE NAKLİ: GERÇEK YAŞAM VERİSİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.

14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 Mart 2022, (Tam Metin Bildiri)

14. GRAFT VERSUS HOST HASTALIĞI PROFİLAKSİSİNDE ATG VE POST CY KULLANIMININ NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

Karakaya B., ŞAHİN Y. İ., MAMMADLI H., Yavuz G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., et al.

14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 Mart 2022, (Tam Metin Bildiri)

15. THE OUTCOME OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN LYPHOMA

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

63TH ASH CONGRESS, ATLANTA, Amerika Birleşik Devletleri, 8 - 11 Aralık 2021, (Tam Metin Bildiri)

16. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.

63rd ASH Annual Meeting and Exposition, 11 Aralık 2021, (Tam Metin Bildiri)

17. PROFLAKTİK DEFİBROTİD SOS DIŞINDA AKUT GRAFT VS HOST HASTALIĞINDA DA ETKİN

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.

47. Ulusal Hematoloji Kongresi, 04 Kasım 2021, (Tam Metin Bildiri)

18. Allojenik Kök Hücre Nakli Hastalarında Peritransplant Metronidazol Kullanımıyla Akut GVHD Riskinin İlişkisi

KIRCALİ E., SEVAL G. C., Öztürk C., CİVRİZ BOZDAĞ S., YÜKSEL M. K., TOPÇUOĞLU P., et al.

13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

19. MULTİPL MİYELOMDA OTOLOG PRİFERİK KÖK HÜCRE NAKLİ SONRASI ERKEN NÜKSÜ BELİRLEMEDE CIBMTR, ISS VE R-ISS SKORLAMA SİSTEMLERİNİN KARŞILAŞTIRILMASI

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 Nisan 2021, (Tam Metin Bildiri)

20. Relaps/Refrakter Hodgkin Lenfoma Hastalarında Allojenik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

KOYUN D., ŞAHİN U., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., et al.

13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

21. Solid Organ Nakli Ve Allojenik Kök Hücre Nakli Sonrası Gelişen Post-Transplant Lenfoproliferatif Hastalık- Tek Merkez Deneyimi

Öztürk C., KIRCALİ E., KOYUN D., YILMAZ H., YAVUZ G., KARAKAYA B., et al.

13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

22. ALLOJENİK KÖK HÜCRE NAKLİ HASTALARINDA PERİTRANSPLANT METRONİDAZOL KULLANIMIYLA AKUT GVHD RİSKİNİN İLİŞKİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 Nisan 2021, (Tam Metin Bildiri)

23. THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., Yavuz G., et al.

8 45 th International Congress on Leukemia Lymphoma Myeloma, Ankara, Türkiye, 21 Mayıs 2021, cilt.38, sa.71, ss.1-81, (Tam Metin Bildiri)

24. The impact of pretransplant ımmunomodulatory drugs on cmv reactıvatıon

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., YAVUZ G., et al.

8th International congress on leukemia lymphoma myeloma, 2021, 21 Mayıs 2021, (Tam Metin Bildiri)

25. Comparative Analysis and Validation of CIBMTR Early Relapse Risk Score with ISS and R-ISS: Single Center Experience from Ankara University

SEVAL G. C., BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 08 Şubat 2021, (Tam Metin Bildiri)

26. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients

KIRCALİ E., SEVAL G. C., ÖZTÜRK C., BOZDAĞ S., YÜKSEL M. K., TOPÇUOĞLU P., et al.

Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 8 - 12 Şubat 2021, (Tam Metin Bildiri)

27. Foliküler lenfomada bazal PET'te toplam metabolik tümör hacmi ve toplan lezyon glikolizinin prognostik önemi.

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., ÖZKAN E., et al.

46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020, (Tam Metin Bildiri)

28. AKUT MYELOBLASTİK LÖSEMİ HASTALARINDA NÜKLEOFOSMİN MUTASYONU MİNİMAL REZİDÜEL HASTALIK TAKİBİNDE YOL GÖSTERİCİMİDİR

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.

42.Ulusal Hematoloji Kongresi, Türkiye, 28 - 30 Ekim 2020, (Tam Metin Bildiri)

29. Role Of Chımerısm And Flow-Cytometrıc Monıtorıng Of Measurable Resıdualdısease (Mrd) After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon (Allohsct) In Predıctıng Relapse In Acute Myeloıd Leukemıa (AML)

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., DALVA K., et al.

46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT, 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

30. Flamsa-Based Hıgh-Dose Sequentıal Condıtıonıng Regımen Followed By Allogeneıc Hematopoıetıc Stem Cell Transplantatıon (Allo-Hsct): Is It Effectıveın Patıents Wıth Prımary Refractory Or Relapsed Acute Leukemıa?

CENGİZ SEVAL G., EKİN K., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

31. The Influence Of Antı-Thymocyte Globulın (Atg) On The Outcomes Of Patıents Wıth Aml W/Wo Measurable Resıdual Dısease (Mrd) At The Tıme Of Unrelated Donor Transplantatıon

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., KIRCALİ E., BALTACI M. A., TOPÇUOĞLU P., et al.

46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

32. Treatment Of Thrombocytopenıa After Allogeneıc Stem Cell Transplantatıonwıth Eltrombopag

KIRCALİ E., CENGİZ SEVAL G., KOYUN D., ÖZTÜRK C., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.

46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

33. Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience.

Demirer T., Seval G. C., Bozdag S. C., Toprak S. K., Yuksel M. K., Topcuoglu P., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38, (Özet Bildiri)

34. AML TANISI İLE AKRABA DIŞI VERİCİDEN AHKHN YAPILAN HASTALARDA ATG KULLANIMININ NAKİL SONUÇLARINA ETKİSİ

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.

12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

35. HEMORAJİK SİSTİT İÇİN YARGILANAN SİKLOFOSFAMİD SUÇSUZ BULUNDU: TEK MERKEZ 7 YILLIK DENEYİM

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.

12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

36. CD34 VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.

12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

37. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow

CENGİZ SEVAL G., USLU A., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, 19 - 23 Şubat 2020, (Tam Metin Bildiri)

38. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., ÖZTÜRK N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR 2020, 19 - 23 Şubat 2020, (Tam Metin Bildiri)

39. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., USLU A., KİRCALİ E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.

61st ASH Annual Meeting and Exposition, NY, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.26, ss.305-306, (Özet Bildiri)

40. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

SEVAL G. C., Öztürk n., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

61st ASH Annual Meeting, 7 - 10 Aralık 2019, (Tam Metin Bildiri)

41. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., Uslu A., Kircali E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

42. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Ozturk N., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

43. Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Kircali E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

44. KRONİK MİYELOİD LOSEMİ (KML) HASTALARINDA KML KOKHUCRESİ BCR- ABL’DEN BAĞIMSIZ PROGNOSTİK BİR FAKTOR OLABİLİR Mİ?

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.

45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)

45. HANGİSİ, ORJİNAL İMATİNİB Mİ JENERİK Mİ KRONİK MYELOİD LÖSEMİDE DAHA ETKİN?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.

45. Ulusal Hematoloji Kongresi, 31 Ekim 2019, (Tam Metin Bildiri)

46. YENİ TANI KLL HASTALARINDA TANI SIRASINDAKİ CD49DEKSPRESYONUNUN HASTALIĞA OZGU BAŞKA PARAMETRELERLEİLİŞKİSİ

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.

45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)

47. Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.

17th International Myeloma Workshop, 12 - 15 Eylül 2019, (Tam Metin Bildiri)

48. Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.382, (Özet Bildiri)

49. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?

YÜKSEL M., CENGİZ SEVAL G., Uslu A., Kircili E., KOYUN D., Ozturk C., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.505-506, (Özet Bildiri)

50. Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.500, (Özet Bildiri)

51. Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.

24 Congress of the European Hematology Association, 13 - 16 Haziran 2019, (Özet Bildiri)

52. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)

53. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

Ilhan O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)

54. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)

55. retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.

ICLLM 2019, 02 Mayıs 2019, (Tam Metin Bildiri)

56. CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION

Yüksel M., Kırcalı E., Cengiz Seval G., Koyun D., Uslu A., Öztürk C., et al.

7th International Congress on Leukemia Lymphoma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)